Improved neuropsychological and neurological functioning across three antiretroviral regimens in diverse resource-limited settings: Aids clinical trials group study A5199, the international neurological study

• Main Authors: K. Robertson, H. Jiang, J. Kumwenda, K. Supparatpinyo, S. Evans, T. B. Campbell, R. Price, S. Tripathy, N. Kumarasamy, A. La Rosa, B. Santos, M. T. Silva, S. Montano, C. Kanyama, S. Faesen, R. Murphy, C. Hall, C. M. Marra, C. Marcus, B. Berzins, R. Allen, M. Housseinipour, F. Amod, I. Sanne, J. Hakim, A. Walawander, A. Nair
• 格式: 雜誌
• 出版: 2018
• 主題: Medicine
• 在線閱讀: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84865482221&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/51855
• 機構: Chiang Mai University

Background. AIDS Clinical Trials Group (ACTG) A5199 compared the neurological and neuropsychological (NP) effects of 3 antiretroviral regimens in participants infected with human immunodeficiency virus type 1 (HIV-1) in resource-limited settings.Methods.Participants from Brazil, India, Malawi, Peru,...